JP2004538316A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004538316A5 JP2004538316A5 JP2003517059A JP2003517059A JP2004538316A5 JP 2004538316 A5 JP2004538316 A5 JP 2004538316A5 JP 2003517059 A JP2003517059 A JP 2003517059A JP 2003517059 A JP2003517059 A JP 2003517059A JP 2004538316 A5 JP2004538316 A5 JP 2004538316A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- pyrimidine
- dione
- thieno
- ylcarbonyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims description 80
- 229910052757 nitrogen Inorganic materials 0.000 claims description 48
- 150000001875 compounds Chemical class 0.000 claims description 39
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 35
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 34
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 30
- -1 isoxazolidin-2-ylcarbonyl Chemical group 0.000 claims description 30
- 125000003545 alkoxy group Chemical group 0.000 claims description 27
- 125000003118 aryl group Chemical group 0.000 claims description 24
- 125000000623 heterocyclic group Chemical group 0.000 claims description 24
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 24
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 19
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 19
- 229910052760 oxygen Inorganic materials 0.000 claims description 19
- 239000001301 oxygen Chemical group 0.000 claims description 19
- 229910052717 sulfur Chemical group 0.000 claims description 19
- 239000011593 sulfur Chemical group 0.000 claims description 19
- 125000005842 heteroatom Chemical group 0.000 claims description 18
- 125000001424 substituent group Chemical group 0.000 claims description 18
- 125000004414 alkyl thio group Chemical group 0.000 claims description 16
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 16
- 125000001589 carboacyl group Chemical group 0.000 claims description 16
- 229910052736 halogen Inorganic materials 0.000 claims description 16
- 150000002367 halogens Chemical class 0.000 claims description 16
- 150000003839 salts Chemical class 0.000 claims description 16
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 15
- 125000004043 oxo group Chemical group O=* 0.000 claims description 15
- 125000004385 trihaloalkyl group Chemical group 0.000 claims description 15
- 125000004122 cyclic group Chemical group 0.000 claims description 14
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 14
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 13
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 12
- 125000004982 dihaloalkyl group Chemical group 0.000 claims description 12
- 125000001188 haloalkyl group Chemical group 0.000 claims description 12
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 12
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 11
- 125000000464 thioxo group Chemical group S=* 0.000 claims description 11
- 125000005115 alkyl carbamoyl group Chemical group 0.000 claims description 8
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 7
- 125000002861 (C1-C4) alkanoyl group Chemical group 0.000 claims description 6
- 125000004769 (C1-C4) alkylsulfonyl group Chemical group 0.000 claims description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 6
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 claims description 6
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 6
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 6
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 6
- 125000004768 (C1-C4) alkylsulfinyl group Chemical group 0.000 claims description 5
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 5
- 125000006413 ring segment Chemical group 0.000 claims description 5
- 125000003342 alkenyl group Chemical group 0.000 claims description 4
- 125000001340 2-chloroethyl group Chemical group [H]C([H])(Cl)C([H])([H])* 0.000 claims description 3
- 125000005843 halogen group Chemical group 0.000 claims description 3
- 239000000651 prodrug Substances 0.000 claims description 3
- 229940002612 prodrug Drugs 0.000 claims description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 3
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 claims description 2
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 2
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 claims description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 2
- 125000002883 imidazolyl group Chemical group 0.000 claims description 2
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 claims description 2
- 125000001041 indolyl group Chemical group 0.000 claims description 2
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 2
- 125000005493 quinolyl group Chemical group 0.000 claims description 2
- 239000012453 solvate Substances 0.000 claims description 2
- 238000000034 method Methods 0.000 claims 4
- JGOOQALRLGHKIY-UHFFFAOYSA-N 1h-thieno[2,3-d]pyrimidine-2,4-dione Chemical compound O=C1NC(=O)NC2=C1C=CS2 JGOOQALRLGHKIY-UHFFFAOYSA-N 0.000 claims 3
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims 3
- ZIQASVKKDANPDO-ABLWVSNPSA-N 5-(4-hydroxy-1,2-oxazolidine-2-carbonyl)-3-methyl-6-[[(2s)-6-methyl-3-oxo-2h-pyrazin-2-yl]methyl]-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1C(O)CON1C(=O)C=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1C[C@@H]1N=C(C)C=NC1=O ZIQASVKKDANPDO-ABLWVSNPSA-N 0.000 claims 2
- XEVQNMOABVOAGK-OAHLLOKOSA-N 5-[(4r)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-6-[(2-methyl-1h-indol-3-yl)methyl]-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC(CC=2C3=CC=CC=C3NC=2C)=C1C(=O)N1C[C@@H](O)CO1 XEVQNMOABVOAGK-OAHLLOKOSA-N 0.000 claims 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims 2
- CIISBYKBBMFLEZ-UHFFFAOYSA-N 1,2-oxazolidine Chemical compound C1CNOC1 CIISBYKBBMFLEZ-UHFFFAOYSA-N 0.000 claims 1
- WDSFWGBGFCBBHF-HNNXBMFYSA-N 1-[[1-ethyl-5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-2,4-dioxothieno[2,3-d]pyrimidin-6-yl]methyl]indole-5-carbonitrile Chemical compound C1=2C(=O)N(C)C(=O)N(CC)C=2SC(CN2C3=CC=C(C=C3C=C2)C#N)=C1C(=O)N1C[C@H](O)CO1 WDSFWGBGFCBBHF-HNNXBMFYSA-N 0.000 claims 1
- MMEGHQPYDCKIFC-LBPRGKRZSA-N 1-ethyl-5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-6-(1h-pyrrolo[2,3-b]pyridin-3-ylmethyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(CC)C=2SC(CC=2C3=CC=CN=C3NC=2)=C1C(=O)N1C[C@H](O)CO1 MMEGHQPYDCKIFC-LBPRGKRZSA-N 0.000 claims 1
- ZHWYUYWJISNICI-LBPRGKRZSA-N 1-ethyl-5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-6-[(2-methyl-1h-pyrrolo[2,3-b]pyridin-3-yl)methyl]thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(CC)C=2SC(CC=2C3=CC=CN=C3NC=2C)=C1C(=O)N1C[C@H](O)CO1 ZHWYUYWJISNICI-LBPRGKRZSA-N 0.000 claims 1
- MODGZFYFFURRKI-NSHDSACASA-N 1-ethyl-5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-6-[(2-oxo-1,3-benzothiazol-3-yl)methyl]thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(CC)C=2SC(CN2C(SC3=CC=CC=C32)=O)=C1C(=O)N1C[C@H](O)CO1 MODGZFYFFURRKI-NSHDSACASA-N 0.000 claims 1
- OAOKFYWAUWUPNT-UHFFFAOYSA-N 5-(4-hydroxy-1,2-oxazolidine-2-carbonyl)-3-methyl-1-(2-methylpropyl)-6-(quinolin-5-ylmethyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC(CC=2C3=CC=CN=C3C=CC=2)=C1C(=O)N1CC(O)CO1 OAOKFYWAUWUPNT-UHFFFAOYSA-N 0.000 claims 1
- FOUGTHXAKKBTGL-MRXNPFEDSA-N 5-[(4r)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-(2-methylpropyl)-6-(quinolin-4-ylmethyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC(CC=2C3=CC=CC=C3N=CC=2)=C1C(=O)N1C[C@@H](O)CO1 FOUGTHXAKKBTGL-MRXNPFEDSA-N 0.000 claims 1
- HMICMRQBKBXVSC-AWEZNQCLSA-N 5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-(2-methylpropyl)-6-(1h-pyrrolo[2,3-b]pyridin-3-ylmethyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC(CC=2C3=CC=CN=C3NC=2)=C1C(=O)N1C[C@H](O)CO1 HMICMRQBKBXVSC-AWEZNQCLSA-N 0.000 claims 1
- ZNHPAUWDRKNNNX-HNNXBMFYSA-N 5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-(2-methylpropyl)-6-(pyrrolo[2,3-b]pyridin-1-ylmethyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC(CN2C3=NC=CC=C3C=C2)=C1C(=O)N1C[C@H](O)CO1 ZNHPAUWDRKNNNX-HNNXBMFYSA-N 0.000 claims 1
- FOUGTHXAKKBTGL-INIZCTEOSA-N 5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-(2-methylpropyl)-6-(quinolin-4-ylmethyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC(CC=2C3=CC=CC=C3N=CC=2)=C1C(=O)N1C[C@H](O)CO1 FOUGTHXAKKBTGL-INIZCTEOSA-N 0.000 claims 1
- OKAJAHIFZHXGQD-AWEZNQCLSA-N 5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-(2-methylpropyl)-6-(quinoline-4-carbonyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC(C(=O)C=2C3=CC=CC=C3N=CC=2)=C1C(=O)N1C[C@H](O)CO1 OKAJAHIFZHXGQD-AWEZNQCLSA-N 0.000 claims 1
- SYABSTPXYAKTOJ-AWEZNQCLSA-N 5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-(2-methylpropyl)-6-[(1,3,5-trimethylpyrazol-4-yl)methyl]thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C([C@@H](O)C1)ON1C(=O)C=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1CC=1C(C)=NN(C)C=1C SYABSTPXYAKTOJ-AWEZNQCLSA-N 0.000 claims 1
- VFHHJCWOWISPED-KRWDZBQOSA-N 5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-(2-methylpropyl)-6-[(2-methylquinolin-4-yl)methyl]thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC(CC=2C3=CC=CC=C3N=C(C)C=2)=C1C(=O)N1C[C@H](O)CO1 VFHHJCWOWISPED-KRWDZBQOSA-N 0.000 claims 1
- HPEIANKQXRRLBL-AWEZNQCLSA-N 5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-(2-methylpropyl)-6-[(2-methylsulfanylbenzimidazol-1-yl)methyl]thieno[2,3-d]pyrimidine-2,4-dione Chemical compound CSC1=NC2=CC=CC=C2N1CC=1SC=2N(CC(C)C)C(=O)N(C)C(=O)C=2C=1C(=O)N1C[C@H](O)CO1 HPEIANKQXRRLBL-AWEZNQCLSA-N 0.000 claims 1
- LCHHQJNRBXXZHG-ZDUSSCGKSA-N 5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-(2-methylpropyl)-6-[(2-methylsulfanylimidazo[4,5-b]pyridin-1-yl)methyl]thieno[2,3-d]pyrimidine-2,4-dione Chemical compound CSC1=NC2=NC=CC=C2N1CC=1SC=2N(CC(C)C)C(=O)N(C)C(=O)C=2C=1C(=O)N1C[C@H](O)CO1 LCHHQJNRBXXZHG-ZDUSSCGKSA-N 0.000 claims 1
- HIQNRBQEGNXQIY-ZDUSSCGKSA-N 5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-(2-methylpropyl)-6-[(2-methylsulfanylimidazo[4,5-b]pyridin-3-yl)methyl]thieno[2,3-d]pyrimidine-2,4-dione Chemical compound CSC1=NC2=CC=CN=C2N1CC=1SC=2N(CC(C)C)C(=O)N(C)C(=O)C=2C=1C(=O)N1C[C@H](O)CO1 HIQNRBQEGNXQIY-ZDUSSCGKSA-N 0.000 claims 1
- IBBQWKIRDFVRSO-ZDUSSCGKSA-N 5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-(2-methylpropyl)-6-[(2-oxo-1,3-benzothiazol-3-yl)methyl]thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC(CN2C(SC3=CC=CC=C32)=O)=C1C(=O)N1C[C@H](O)CO1 IBBQWKIRDFVRSO-ZDUSSCGKSA-N 0.000 claims 1
- KDYIYJROCHINAC-ZDUSSCGKSA-N 5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-(2-methylpropyl)-6-[(2-oxo-1,3-benzoxazol-3-yl)methyl]thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC(CN2C(OC3=CC=CC=C32)=O)=C1C(=O)N1C[C@H](O)CO1 KDYIYJROCHINAC-ZDUSSCGKSA-N 0.000 claims 1
- MONIFZUOJGZTAE-ZDUSSCGKSA-N 5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-(2-methylpropyl)-6-[(2-oxo-3h-benzimidazol-1-yl)methyl]thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC(CN2C(NC3=CC=CC=C32)=O)=C1C(=O)N1C[C@H](O)CO1 MONIFZUOJGZTAE-ZDUSSCGKSA-N 0.000 claims 1
- GMUYBYWHRGVEIG-INIZCTEOSA-N 5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-(2-methylpropyl)-6-[(2-propylbenzimidazol-1-yl)methyl]thieno[2,3-d]pyrimidine-2,4-dione Chemical compound CCCC1=NC2=CC=CC=C2N1CC=1SC=2N(CC(C)C)C(=O)N(C)C(=O)C=2C=1C(=O)N1C[C@H](O)CO1 GMUYBYWHRGVEIG-INIZCTEOSA-N 0.000 claims 1
- HWCXNAYSPUDWJO-ZDUSSCGKSA-N 5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-(2-methylpropyl)-6-[(2-sulfanylidene-1,3-benzothiazol-3-yl)methyl]thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC(CN2C(SC3=CC=CC=C32)=S)=C1C(=O)N1C[C@H](O)CO1 HWCXNAYSPUDWJO-ZDUSSCGKSA-N 0.000 claims 1
- GOSZMIDOMHVHDD-AWEZNQCLSA-N 5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-(2-methylpropyl)-6-[[2-(trifluoromethyl)phenyl]methyl]thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C([C@@H](O)C1)ON1C(=O)C=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1CC1=CC=CC=C1C(F)(F)F GOSZMIDOMHVHDD-AWEZNQCLSA-N 0.000 claims 1
- IJOXULDVIPXPSA-NSHDSACASA-N 5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-(2-methylpropyl)-6-[[5-methyl-3-(trifluoromethyl)-1h-pyrazol-4-yl]methyl]thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C([C@@H](O)C1)ON1C(=O)C=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1CC1=C(C)NN=C1C(F)(F)F IJOXULDVIPXPSA-NSHDSACASA-N 0.000 claims 1
- CMNXDCPCRZRYRA-ZDUSSCGKSA-N 5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-propan-2-yl-6-(1h-pyrrolo[2,3-b]pyridin-3-ylmethyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(C(C)C)C=2SC(CC=2C3=CC=CN=C3NC=2)=C1C(=O)N1C[C@H](O)CO1 CMNXDCPCRZRYRA-ZDUSSCGKSA-N 0.000 claims 1
- MXQQSPJNKRUPKR-HNNXBMFYSA-N 5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-propan-2-yl-6-(quinolin-4-ylmethyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(C(C)C)C=2SC(CC=2C3=CC=CC=C3N=CC=2)=C1C(=O)N1C[C@H](O)CO1 MXQQSPJNKRUPKR-HNNXBMFYSA-N 0.000 claims 1
- PDNPKVIMVPDBRT-ZDUSSCGKSA-N 5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-propyl-6-(1h-pyrrolo[2,3-b]pyridin-3-ylmethyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(CCC)C=2SC(CC=2C3=CC=CN=C3NC=2)=C1C(=O)N1C[C@H](O)CO1 PDNPKVIMVPDBRT-ZDUSSCGKSA-N 0.000 claims 1
- HUXYVUKYQUIKAF-AWEZNQCLSA-N 5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-6-(2-methyl-1h-indole-3-carbonyl)-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC(C(=O)C=2C3=CC=CC=C3NC=2C)=C1C(=O)N1C[C@H](O)CO1 HUXYVUKYQUIKAF-AWEZNQCLSA-N 0.000 claims 1
- XEVQNMOABVOAGK-HNNXBMFYSA-N 5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-6-[(2-methyl-1h-indol-3-yl)methyl]-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC(CC=2C3=CC=CC=C3NC=2C)=C1C(=O)N1C[C@H](O)CO1 XEVQNMOABVOAGK-HNNXBMFYSA-N 0.000 claims 1
- WCXCSEWUMQNJDV-ZDUSSCGKSA-N 5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-6-[(2-methyl-1h-pyrrolo[2,3-b]pyridin-3-yl)methyl]-1-propan-2-ylthieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(C(C)C)C=2SC(CC=2C3=CC=CN=C3NC=2C)=C1C(=O)N1C[C@H](O)CO1 WCXCSEWUMQNJDV-ZDUSSCGKSA-N 0.000 claims 1
- LGTFKFFKZHGUGS-HNNXBMFYSA-N 5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-6-[(2-methylbenzimidazol-1-yl)methyl]-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC(CN2C3=CC=CC=C3N=C2C)=C1C(=O)N1C[C@H](O)CO1 LGTFKFFKZHGUGS-HNNXBMFYSA-N 0.000 claims 1
- BUSGBWGCDVCDHH-HNNXBMFYSA-N 5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-6-[(2-methylpyrrolo[2,3-b]pyridin-1-yl)methyl]-1-propan-2-ylthieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(C(C)C)C=2SC(CN2C3=NC=CC=C3C=C2C)=C1C(=O)N1C[C@H](O)CO1 BUSGBWGCDVCDHH-HNNXBMFYSA-N 0.000 claims 1
- YVJYZPRWQVUGQK-LBPRGKRZSA-N 5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-6-[(2-oxo-3h-benzimidazol-1-yl)methyl]-1-propan-2-ylthieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(C(C)C)C=2SC(CN2C(NC3=CC=CC=C32)=O)=C1C(=O)N1C[C@H](O)CO1 YVJYZPRWQVUGQK-LBPRGKRZSA-N 0.000 claims 1
- CYXVQFUBNAVJSY-KRWDZBQOSA-N 5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-6-[(5-methyl-3-phenyl-1h-pyrazol-4-yl)methyl]-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C([C@@H](O)C1)ON1C(=O)C=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1CC1=C(C)NN=C1C1=CC=CC=C1 CYXVQFUBNAVJSY-KRWDZBQOSA-N 0.000 claims 1
- XIXMTIJQLLRJIJ-AWEZNQCLSA-N 5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-6-[(5-methyl-3-propan-2-yl-1h-pyrazol-4-yl)methyl]-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C([C@@H](O)C1)ON1C(=O)C=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1CC1=C(C)NN=C1C(C)C XIXMTIJQLLRJIJ-AWEZNQCLSA-N 0.000 claims 1
- RBMGZPYCDQPSLS-AWEZNQCLSA-N 5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-6-[[2-(methylamino)benzimidazol-1-yl]methyl]-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound CNC1=NC2=CC=CC=C2N1CC=1SC=2N(CC(C)C)C(=O)N(C)C(=O)C=2C=1C(=O)N1C[C@H](O)CO1 RBMGZPYCDQPSLS-AWEZNQCLSA-N 0.000 claims 1
- HAFALVDBJMSQDY-ZDUSSCGKSA-N 5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-6-[[2-(methylamino)benzimidazol-1-yl]methyl]-1-propan-2-ylthieno[2,3-d]pyrimidine-2,4-dione Chemical compound CNC1=NC2=CC=CC=C2N1CC=1SC=2N(C(C)C)C(=O)N(C)C(=O)C=2C=1C(=O)N1C[C@H](O)CO1 HAFALVDBJMSQDY-ZDUSSCGKSA-N 0.000 claims 1
- QLLQXUZUDUJVPE-LBPRGKRZSA-N 5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-6-[[2-(methylamino)imidazo[4,5-b]pyridin-3-yl]methyl]-1-propylthieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(CCC)C=2SC(CN2C3=NC=CC=C3N=C2NC)=C1C(=O)N1C[C@H](O)CO1 QLLQXUZUDUJVPE-LBPRGKRZSA-N 0.000 claims 1
- PHTPNKIHLRLMJH-HNNXBMFYSA-N 5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-6-(imidazo[1,2-a]pyridin-3-ylmethyl)-3-methyl-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC(CC=2N3C=CC=CC3=NC=2)=C1C(=O)N1C[C@H](O)CO1 PHTPNKIHLRLMJH-HNNXBMFYSA-N 0.000 claims 1
- LATSXWIPGFHYDG-ZDUSSCGKSA-N 6-(benzotriazol-1-ylmethyl)-5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC(CN2C3=CC=CC=C3N=N2)=C1C(=O)N1C[C@H](O)CO1 LATSXWIPGFHYDG-ZDUSSCGKSA-N 0.000 claims 1
- MNNWRXMQFXOPNJ-LBPRGKRZSA-N 6-(benzotriazol-1-ylmethyl)-5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-propan-2-ylthieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(C(C)C)C=2SC(CN2C3=CC=CC=C3N=N2)=C1C(=O)N1C[C@H](O)CO1 MNNWRXMQFXOPNJ-LBPRGKRZSA-N 0.000 claims 1
- SALVKLFWQWNMJO-ZDUSSCGKSA-N 6-[(2-aminobenzimidazol-1-yl)methyl]-5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC(CN2C3=CC=CC=C3N=C2N)=C1C(=O)N1C[C@H](O)CO1 SALVKLFWQWNMJO-ZDUSSCGKSA-N 0.000 claims 1
- OFTBDTAMUXEDOO-LBPRGKRZSA-N 6-[(2-aminobenzimidazol-1-yl)methyl]-5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-propan-2-ylthieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(C(C)C)C=2SC(CN2C3=CC=CC=C3N=C2N)=C1C(=O)N1C[C@H](O)CO1 OFTBDTAMUXEDOO-LBPRGKRZSA-N 0.000 claims 1
- ZHWJLKCQMOWILZ-LBPRGKRZSA-N 6-[(2-aminobenzimidazol-1-yl)methyl]-5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-propylthieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(CCC)C=2SC(CN2C3=CC=CC=C3N=C2N)=C1C(=O)N1C[C@H](O)CO1 ZHWJLKCQMOWILZ-LBPRGKRZSA-N 0.000 claims 1
- GSGSGKQSENPYHG-VIFPVBQESA-N 6-[(2-bromo-4,5-dichloroimidazol-1-yl)methyl]-5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C([C@@H](O)C1)ON1C(=O)C=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1CN1C(Br)=NC(Cl)=C1Cl GSGSGKQSENPYHG-VIFPVBQESA-N 0.000 claims 1
- RECMMXWFDZIIOE-HNNXBMFYSA-N 6-[(2-ethylbenzimidazol-1-yl)methyl]-5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound CCC1=NC2=CC=CC=C2N1CC=1SC=2N(CC(C)C)C(=O)N(C)C(=O)C=2C=1C(=O)N1C[C@H](O)CO1 RECMMXWFDZIIOE-HNNXBMFYSA-N 0.000 claims 1
- ZOIKLFOXYZTZJG-ZDUSSCGKSA-N 6-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]-5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C([C@@H](O)C1)ON1C(=O)C=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1CC=1C(C)=NOC=1C ZOIKLFOXYZTZJG-ZDUSSCGKSA-N 0.000 claims 1
- NWDXTHRUMCBLPT-IBGZPJMESA-N 6-[(3,5-dimethyl-1-phenylpyrazol-4-yl)methyl]-5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C([C@@H](O)C1)ON1C(=O)C=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1CC(=C1C)C(C)=NN1C1=CC=CC=C1 NWDXTHRUMCBLPT-IBGZPJMESA-N 0.000 claims 1
- UAXYKEAANLHJGN-SFHVURJKSA-N 6-[(3,5-dimethyl-1-phenylpyrazol-4-yl)methyl]-5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-propylthieno[2,3-d]pyrimidine-2,4-dione Chemical compound C([C@@H](O)C1)ON1C(=O)C=1C=2C(=O)N(C)C(=O)N(CCC)C=2SC=1CC(=C1C)C(C)=NN1C1=CC=CC=C1 UAXYKEAANLHJGN-SFHVURJKSA-N 0.000 claims 1
- VCFBFOISICPBER-INIZCTEOSA-N 6-[(3,5-dimethyl-1-propan-2-ylpyrazol-4-yl)methyl]-5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C([C@@H](O)C1)ON1C(=O)C=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1CC=1C(C)=NN(C(C)C)C=1C VCFBFOISICPBER-INIZCTEOSA-N 0.000 claims 1
- FXYDHGALICIHIR-ZDUSSCGKSA-N 6-[(3,5-dimethyl-1h-pyrazol-4-yl)methyl]-3-ethyl-5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-1-propan-2-ylthieno[2,3-d]pyrimidine-2,4-dione Chemical compound C([C@@H](O)C1)ON1C(=O)C=1C=2C(=O)N(CC)C(=O)N(C(C)C)C=2SC=1CC=1C(C)=NNC=1C FXYDHGALICIHIR-ZDUSSCGKSA-N 0.000 claims 1
- ISIVOJWVBJIOFM-ZDUSSCGKSA-N 6-[(3,5-dimethyl-1h-pyrazol-4-yl)methyl]-5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C([C@@H](O)C1)ON1C(=O)C=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1CC=1C(C)=NNC=1C ISIVOJWVBJIOFM-ZDUSSCGKSA-N 0.000 claims 1
- PYLXXPJXPHUENG-LBPRGKRZSA-N 6-[(3,5-dimethyl-1h-pyrazol-4-yl)methyl]-5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-propan-2-ylthieno[2,3-d]pyrimidine-2,4-dione Chemical compound C([C@@H](O)C1)ON1C(=O)C=1C=2C(=O)N(C)C(=O)N(C(C)C)C=2SC=1CC=1C(C)=NNC=1C PYLXXPJXPHUENG-LBPRGKRZSA-N 0.000 claims 1
- QKBZODOPLHOHSA-LBPRGKRZSA-N 6-[(3,5-dimethyl-1h-pyrazol-4-yl)methyl]-5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-propylthieno[2,3-d]pyrimidine-2,4-dione Chemical compound C([C@@H](O)C1)ON1C(=O)C=1C=2C(=O)N(C)C(=O)N(CCC)C=2SC=1CC=1C(C)=NNC=1C QKBZODOPLHOHSA-LBPRGKRZSA-N 0.000 claims 1
- BMJFGMRXIQQYEH-AWEZNQCLSA-N 6-[(3,5-dimethylpyrazol-1-yl)methyl]-5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C([C@@H](O)C1)ON1C(=O)C=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1CN1N=C(C)C=C1C BMJFGMRXIQQYEH-AWEZNQCLSA-N 0.000 claims 1
- UHGFWWYNEWEFMI-VIFPVBQESA-N 6-[(4,5-dichloro-2-methylimidazol-1-yl)methyl]-1-ethyl-5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methylthieno[2,3-d]pyrimidine-2,4-dione Chemical compound C([C@@H](O)C1)ON1C(=O)C=1C=2C(=O)N(C)C(=O)N(CC)C=2SC=1CN1C(C)=NC(Cl)=C1Cl UHGFWWYNEWEFMI-VIFPVBQESA-N 0.000 claims 1
- IBKJEDNPWVCURQ-LLVKDONJSA-N 6-[(4,5-dichloro-2-methylimidazol-1-yl)methyl]-5-[(4r)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C([C@H](O)C1)ON1C(=O)C=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1CN1C(C)=NC(Cl)=C1Cl IBKJEDNPWVCURQ-LLVKDONJSA-N 0.000 claims 1
- IBKJEDNPWVCURQ-NSHDSACASA-N 6-[(4,5-dichloro-2-methylimidazol-1-yl)methyl]-5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C([C@@H](O)C1)ON1C(=O)C=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1CN1C(C)=NC(Cl)=C1Cl IBKJEDNPWVCURQ-NSHDSACASA-N 0.000 claims 1
- JFIPQSAGONRHIK-JTQLQIEISA-N 6-[(4,5-dichloro-2-methylimidazol-1-yl)methyl]-5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-propylthieno[2,3-d]pyrimidine-2,4-dione Chemical compound C([C@@H](O)C1)ON1C(=O)C=1C=2C(=O)N(C)C(=O)N(CCC)C=2SC=1CN1C(C)=NC(Cl)=C1Cl JFIPQSAGONRHIK-JTQLQIEISA-N 0.000 claims 1
- COYABIKHBNKNNW-VIFPVBQESA-N 6-[(4,5-dichloro-2-oxo-1,3-thiazol-3-yl)methyl]-5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C([C@@H](O)C1)ON1C(=O)C=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1CN1C(Cl)=C(Cl)SC1=O COYABIKHBNKNNW-VIFPVBQESA-N 0.000 claims 1
- OSLGUPFRYKIZPD-JTQLQIEISA-N 6-[(4-chloro-2-oxo-1,3-thiazol-3-yl)methyl]-5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C([C@@H](O)C1)ON1C(=O)C=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1CN1C(Cl)=CSC1=O OSLGUPFRYKIZPD-JTQLQIEISA-N 0.000 claims 1
- PTHUFRQNBGYBIG-NSHDSACASA-N 6-[(5,6-difluoro-2-oxo-3h-benzimidazol-1-yl)methyl]-5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC(CN2C(NC3=CC(F)=C(F)C=C32)=O)=C1C(=O)N1C[C@H](O)CO1 PTHUFRQNBGYBIG-NSHDSACASA-N 0.000 claims 1
- GARDAKJSPJYBGR-INIZCTEOSA-N 6-[(6-fluoroquinolin-4-yl)methyl]-5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC(CC=2C3=CC(F)=CC=C3N=CC=2)=C1C(=O)N1C[C@H](O)CO1 GARDAKJSPJYBGR-INIZCTEOSA-N 0.000 claims 1
- VGGIJLVSICXJBM-HNNXBMFYSA-N 6-[(8-fluoroquinolin-4-yl)methyl]-5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC(CC=2C3=CC=CC(F)=C3N=CC=2)=C1C(=O)N1C[C@H](O)CO1 VGGIJLVSICXJBM-HNNXBMFYSA-N 0.000 claims 1
- UVWGPIMVDAKHKN-AWEZNQCLSA-N 6-[[2-(hydroxymethyl)benzimidazol-1-yl]methyl]-5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC(CN2C3=CC=CC=C3N=C2CO)=C1C(=O)N1C[C@H](O)CO1 UVWGPIMVDAKHKN-AWEZNQCLSA-N 0.000 claims 1
- RJQMDTLQTXDQAV-ZDUSSCGKSA-N 6-[[2-(hydroxymethyl)benzimidazol-1-yl]methyl]-5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-propan-2-ylthieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(C(C)C)C=2SC(CN2C3=CC=CC=C3N=C2CO)=C1C(=O)N1C[C@H](O)CO1 RJQMDTLQTXDQAV-ZDUSSCGKSA-N 0.000 claims 1
- TVOYGIMHJBLGHY-ZDUSSCGKSA-N 6-[[2-(hydroxymethyl)benzimidazol-1-yl]methyl]-5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-propylthieno[2,3-d]pyrimidine-2,4-dione Chemical compound C1=2C(=O)N(C)C(=O)N(CCC)C=2SC(CN2C3=CC=CC=C3N=C2CO)=C1C(=O)N1C[C@H](O)CO1 TVOYGIMHJBLGHY-ZDUSSCGKSA-N 0.000 claims 1
- JJYWRSPCUYGYHF-JTQLQIEISA-N 6-[[4,5-dichloro-2-(hydroxymethyl)imidazol-1-yl]methyl]-5-[(4s)-4-hydroxy-1,2-oxazolidine-2-carbonyl]-3-methyl-1-(2-methylpropyl)thieno[2,3-d]pyrimidine-2,4-dione Chemical compound C([C@@H](O)C1)ON1C(=O)C=1C=2C(=O)N(C)C(=O)N(CC(C)C)C=2SC=1CN1C(CO)=NC(Cl)=C1Cl JJYWRSPCUYGYHF-JTQLQIEISA-N 0.000 claims 1
- 206010062016 Immunosuppression Diseases 0.000 claims 1
- 230000006052 T cell proliferation Effects 0.000 claims 1
- 210000001744 T-lymphocyte Anatomy 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 125000003354 benzotriazolyl group Chemical group N1N=NC2=C1C=CC=C2* 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 125000000524 functional group Chemical group 0.000 claims 1
- 125000005946 imidazo[1,2-a]pyridyl group Chemical group 0.000 claims 1
- 230000001506 immunosuppresive effect Effects 0.000 claims 1
- 125000000842 isoxazolyl group Chemical group 0.000 claims 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 claims 1
- 230000000414 obstructive effect Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 230000035755 proliferation Effects 0.000 claims 1
- 125000000168 pyrrolyl group Chemical group 0.000 claims 1
- 208000023504 respiratory system disease Diseases 0.000 claims 1
- 230000002441 reversible effect Effects 0.000 claims 1
- 238000003786 synthesis reaction Methods 0.000 claims 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 125000004981 cycloalkylmethyl group Chemical group 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 3
- UWYZHKAOTLEWKK-UHFFFAOYSA-N 1,2,3,4-tetrahydroisoquinoline Chemical compound C1=CC=C2CNCCC2=C1 UWYZHKAOTLEWKK-UHFFFAOYSA-N 0.000 description 2
- 125000003282 alkyl amino group Chemical group 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 0 *c1c(*[Al])[s]c(N(*)C(N2*)=O)c1C2=O Chemical compound *c1c(*[Al])[s]c(N(*)C(N2*)=O)c1C2=O 0.000 description 1
- 125000004973 1-butenyl group Chemical group C(=CCC)* 0.000 description 1
- 125000006039 1-hexenyl group Chemical group 0.000 description 1
- 125000006023 1-pentenyl group Chemical group 0.000 description 1
- 125000006017 1-propenyl group Chemical group 0.000 description 1
- KKZUMAMOMRDVKA-UHFFFAOYSA-N 2-chloropropane Chemical group [CH2]C(C)Cl KKZUMAMOMRDVKA-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000004850 cyclobutylmethyl group Chemical group C1(CCC1)C* 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000004851 cyclopentylmethyl group Chemical group C1(CCCC1)C* 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000002829 nitrogen Chemical class 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0118479.5A GB0118479D0 (en) | 2001-07-28 | 2001-07-28 | Novel compounds |
| PCT/GB2002/003399 WO2003011868A1 (en) | 2001-07-28 | 2002-07-24 | Thienopyrimidinediones and their use in the modulation of autoimmune disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004538316A JP2004538316A (ja) | 2004-12-24 |
| JP2004538316A5 true JP2004538316A5 (https=) | 2006-01-12 |
| JP4456364B2 JP4456364B2 (ja) | 2010-04-28 |
Family
ID=9919407
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003517059A Expired - Fee Related JP4456364B2 (ja) | 2001-07-28 | 2002-07-24 | チエノピリミジンジオンおよび自己免疫疾患調節におけるその使用 |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US7384950B2 (https=) |
| EP (1) | EP1414825B9 (https=) |
| JP (1) | JP4456364B2 (https=) |
| KR (1) | KR100897469B1 (https=) |
| CN (1) | CN1324033C (https=) |
| AR (1) | AR038000A1 (https=) |
| AT (1) | ATE374204T1 (https=) |
| AU (1) | AU2002319469B2 (https=) |
| BR (1) | BR0211262A (https=) |
| CA (1) | CA2453274A1 (https=) |
| DE (1) | DE60222671T2 (https=) |
| ES (1) | ES2292784T3 (https=) |
| GB (1) | GB0118479D0 (https=) |
| HU (1) | HUP0402336A3 (https=) |
| IL (2) | IL159785A0 (https=) |
| IS (1) | IS2598B (https=) |
| MX (1) | MXPA04000677A (https=) |
| MY (1) | MY138145A (https=) |
| NO (1) | NO328713B1 (https=) |
| NZ (1) | NZ530495A (https=) |
| PL (1) | PL211351B1 (https=) |
| RU (1) | RU2294937C9 (https=) |
| WO (1) | WO2003011868A1 (https=) |
| ZA (1) | ZA200400574B (https=) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9801399D0 (sv) | 1998-04-21 | 1998-04-21 | Astra Pharma Prod | Method and apparatus for filling containers |
| GB0117583D0 (en) * | 2001-07-19 | 2001-09-12 | Astrazeneca Ab | Novel compounds |
| GB0118479D0 (en) * | 2001-07-28 | 2001-09-19 | Astrazeneca Ab | Novel compounds |
| US7718802B2 (en) | 2001-08-10 | 2010-05-18 | Palatin Technologies, Inc. | Substituted melanocortin receptor-specific piperazine compounds |
| US7456184B2 (en) | 2003-05-01 | 2008-11-25 | Palatin Technologies Inc. | Melanocortin receptor-specific compounds |
| US7655658B2 (en) | 2001-08-10 | 2010-02-02 | Palatin Technologies, Inc. | Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds |
| US7732451B2 (en) | 2001-08-10 | 2010-06-08 | Palatin Technologies, Inc. | Naphthalene-containing melanocortin receptor-specific small molecule |
| CA2462200A1 (en) | 2001-08-10 | 2003-02-20 | Palatin Technologies, Inc. | Peptidomimetics of biologically active metallopeptides |
| ATE323702T1 (de) | 2002-08-06 | 2006-05-15 | Astrazeneca Ab | Kondensierte pyridine und pyrimidine mit tie2 (tek) aktivität |
| US6890923B2 (en) * | 2002-12-16 | 2005-05-10 | Astrazeneca Ab | Compounds |
| SE0300119D0 (sv) * | 2003-01-17 | 2003-01-17 | Astrazeneca Ab | Novel compounds |
| RU2332420C2 (ru) * | 2003-01-17 | 2008-08-27 | Астразенека Аб | Тиенопиримидиндионы и их применение в модулировании аутоиммунного заболевания |
| SE0300120D0 (sv) | 2003-01-17 | 2003-01-17 | Astrazeneca Ab | Novel compounds |
| MXPA05009722A (es) * | 2003-03-10 | 2006-03-09 | Schering Corp | Inhibidores heterociclicos de cinasa: metodos de uso y sintesis. |
| US7727991B2 (en) | 2003-05-01 | 2010-06-01 | Palatin Technologies, Inc. | Substituted melanocortin receptor-specific single acyl piperazine compounds |
| US7727990B2 (en) | 2003-05-01 | 2010-06-01 | Palatin Technologies, Inc. | Melanocortin receptor-specific piperazine and keto-piperazine compounds |
| US7968548B2 (en) * | 2003-05-01 | 2011-06-28 | Palatin Technologies, Inc. | Melanocortin receptor-specific piperazine compounds with diamine groups |
| CA2550361C (en) | 2003-12-19 | 2014-04-29 | Prabha Ibrahim | Compounds and methods for development of ret modulators |
| US7550602B1 (en) | 2004-01-14 | 2009-06-23 | Palatin Technologies, Inc. | Small molecule compositions for sexual dysfunction |
| US7709484B1 (en) | 2004-04-19 | 2010-05-04 | Palatin Technologies, Inc. | Substituted melanocortin receptor-specific piperazine compounds |
| US7498342B2 (en) | 2004-06-17 | 2009-03-03 | Plexxikon, Inc. | Compounds modulating c-kit activity |
| CN101076335A (zh) * | 2004-08-18 | 2007-11-21 | 默克公司 | 有丝分裂驱动蛋白抑制剂 |
| AU2006272951A1 (en) | 2005-05-17 | 2007-02-01 | Plexxikon, Inc. | Pyrrol (2,3-b) pyridine derivatives protein kinase inhibitors |
| CN102206216B (zh) | 2005-06-22 | 2014-11-12 | 普莱希科公司 | 作为蛋白质激酶抑制剂的吡咯并[2,3-b]吡啶衍生物 |
| US7834017B2 (en) | 2006-08-11 | 2010-11-16 | Palatin Technologies, Inc. | Diamine-containing, tetra-substituted piperazine compounds having identical 1- and 4-substituents |
| WO2008063888A2 (en) | 2006-11-22 | 2008-05-29 | Plexxikon, Inc. | Compounds modulating c-fms and/or c-kit activity and uses therefor |
| RU2345996C1 (ru) * | 2007-07-17 | 2009-02-10 | Андрей Александрович Иващенко | Аннелированные азагетероциклические амиды, включающие пиримидиновый фрагмент, способ их получения и применения |
| RU2341527C1 (ru) * | 2007-07-17 | 2008-12-20 | Общество С Ограниченной Ответственностью "Исследовательский Институт Химического Разнообразия" | Аннелированные азагетероциклы, включающие пиримидиновый фрагмент, способ их получения и ингибиторы pi3k киназ |
| JP2010533729A (ja) | 2007-07-17 | 2010-10-28 | プレキシコン，インコーポレーテッド | キナーゼ調節のための化合物と方法、及びそのための適応 |
| AR070220A1 (es) * | 2008-01-22 | 2010-03-25 | Boehringer Ingelheim Int | Amino-bencimidazoles sustituidos medicamentos que comprenden dicho compuestos, uso y metodos de fabricacion de los mismos |
| PT2411395E (pt) * | 2009-03-23 | 2013-06-06 | Glenmark Pharmaceuticals Sa | Derivados de furopirimidinadiona como moduladores de trpa1 |
| KR101739994B1 (ko) | 2009-04-03 | 2017-05-25 | 에프. 호프만-라 로슈 아게 | 프로판-１-술폰산 ｛３-［５-（４-클로로-페닐）-１Ｈ-피롤로［２，３-ｂ］피리딘-３-카르보닐］-２，４-디플루오로-페닐｝-아미드 조성물 및 그의 용도 |
| NZ599866A (en) | 2009-11-06 | 2014-09-26 | Plexxikon Inc | Compounds and methods for kinase modulation, and indications therefor |
| KR101911972B1 (ko) | 2011-02-07 | 2018-10-25 | 플렉시콘 인코퍼레이티드 | 키나제 조절을 위한 화합물 및 방법, 및 그에 대한 적응증 |
| TWI558702B (zh) | 2011-02-21 | 2016-11-21 | 普雷辛肯公司 | 醫藥活性物質的固態形式 |
| JP5990980B2 (ja) * | 2012-04-02 | 2016-09-14 | 大日本印刷株式会社 | オランザピンの中間体の製造方法 |
| US9150570B2 (en) | 2012-05-31 | 2015-10-06 | Plexxikon Inc. | Synthesis of heterocyclic compounds |
| AR117469A1 (es) | 2018-12-21 | 2021-08-11 | Merck Patent Gmbh | Derivados de alquino disustituidos |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6469014B1 (en) * | 1997-05-28 | 2002-10-22 | Astrazeneca Ab | Thieno[2,3-d] pyrimidinediones, their preparation and use in therapy |
| SE9702001D0 (sv) | 1997-05-28 | 1997-05-28 | Astra Pharma Prod | Novel compounds |
| IL136499A0 (en) | 1997-12-05 | 2001-06-14 | Astrazeneca Uk Ltd Astrazeneca | Pyrrolo-, thieno-, furano- and pyrazolo-[3,4,d] pypyrrolo-, thieno-, furano- and pyrazolo-[3,4,d] pyridazinone compounds, process for their preparatioridaziones compounds, process for their preparation, pharmaceutical compositions containing them, a n, pharmaceutical compositions containing them, a process for prepating the pharmaceutical compositiprocess for preparing the pharmaceutical compositions, and use thereof ons, and use thereof |
| US6232320B1 (en) | 1998-06-04 | 2001-05-15 | Abbott Laboratories | Cell adhesion-inhibiting antiinflammatory compounds |
| ATE253580T1 (de) * | 1998-08-28 | 2003-11-15 | Astrazeneca Ab | Neue thieno(2,3-d)pyrimidindione, verfahren für ihre herstellung und ihre verwendung in der therapie |
| GB0117583D0 (en) | 2001-07-19 | 2001-09-12 | Astrazeneca Ab | Novel compounds |
| GB0118479D0 (en) * | 2001-07-28 | 2001-09-19 | Astrazeneca Ab | Novel compounds |
| SE0300119D0 (sv) | 2003-01-17 | 2003-01-17 | Astrazeneca Ab | Novel compounds |
| SE0300120D0 (sv) | 2003-01-17 | 2003-01-17 | Astrazeneca Ab | Novel compounds |
| RU2332420C2 (ru) | 2003-01-17 | 2008-08-27 | Астразенека Аб | Тиенопиримидиндионы и их применение в модулировании аутоиммунного заболевания |
-
2001
- 2001-07-28 GB GBGB0118479.5A patent/GB0118479D0/en not_active Ceased
-
2002
- 2002-07-24 RU RU2004102392/04A patent/RU2294937C9/ru not_active IP Right Cessation
- 2002-07-24 EP EP02749055A patent/EP1414825B9/en not_active Expired - Lifetime
- 2002-07-24 BR BR0211262-0A patent/BR0211262A/pt not_active IP Right Cessation
- 2002-07-24 MX MXPA04000677A patent/MXPA04000677A/es active IP Right Grant
- 2002-07-24 KR KR1020047001192A patent/KR100897469B1/ko not_active Expired - Fee Related
- 2002-07-24 CN CNB028152506A patent/CN1324033C/zh not_active Expired - Fee Related
- 2002-07-24 US US10/483,162 patent/US7384950B2/en not_active Expired - Fee Related
- 2002-07-24 IL IL15978502A patent/IL159785A0/xx unknown
- 2002-07-24 AU AU2002319469A patent/AU2002319469B2/en not_active Ceased
- 2002-07-24 HU HU0402336A patent/HUP0402336A3/hu unknown
- 2002-07-24 CA CA002453274A patent/CA2453274A1/en not_active Abandoned
- 2002-07-24 ES ES02749055T patent/ES2292784T3/es not_active Expired - Lifetime
- 2002-07-24 NZ NZ530495A patent/NZ530495A/en not_active IP Right Cessation
- 2002-07-24 PL PL369232A patent/PL211351B1/pl not_active IP Right Cessation
- 2002-07-24 DE DE60222671T patent/DE60222671T2/de not_active Expired - Lifetime
- 2002-07-24 WO PCT/GB2002/003399 patent/WO2003011868A1/en not_active Ceased
- 2002-07-24 JP JP2003517059A patent/JP4456364B2/ja not_active Expired - Fee Related
- 2002-07-24 AT AT02749055T patent/ATE374204T1/de not_active IP Right Cessation
- 2002-07-26 MY MYPI20022835A patent/MY138145A/en unknown
- 2002-07-26 AR ARP020102842A patent/AR038000A1/es active IP Right Grant
-
2004
- 2004-01-08 IL IL159785A patent/IL159785A/en not_active IP Right Cessation
- 2004-01-19 IS IS7118A patent/IS2598B/is unknown
- 2004-01-26 ZA ZA200400574A patent/ZA200400574B/en unknown
- 2004-01-27 NO NO20040364A patent/NO328713B1/no not_active IP Right Cessation
-
2008
- 2008-04-29 US US12/111,792 patent/US20080207642A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004538316A5 (https=) | ||
| RU2004102392A (ru) | Тиенопиримидиндионы и их использование в модулировании аутоиммунных заболеваний | |
| US12331056B2 (en) | SHP2 phosphatase inhibitors and methods of use thereof | |
| AU2019203444B2 (en) | Bicyclic lactams and methods of use thereof | |
| AU2011240808B2 (en) | 5, 7-substituted-imidazo [1, 2-c] pyrimidines as inhibitors of JAK kinases | |
| AU2010249380B2 (en) | N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as Janus kinase inhibitors | |
| RU2331647C2 (ru) | Тиенопиримидиндионы и их применение в модулировании аутоиммунного заболевания | |
| JP2004537557A5 (https=) | ||
| ES2268059T3 (es) | Tieno (2,3-d) pirimidindionas como inhibidores de la proliferacion de celulas t. | |
| JP2006516974A5 (https=) | ||
| RU2010139566A (ru) | Пирролопиразиновые ингибиторы киназы | |
| EP2569314A1 (en) | Fused bicyclic kinase inhibitors | |
| RU2846525C2 (ru) | Ингибиторы shp2 фосфатазы и способы их применения | |
| CA3257152A1 (en) | Pyrrolidine derivatives useful as NF-κB induction kinase inhibitors | |
| BR112018000080B1 (pt) | Lactamas bicíclicas e métodos de uso das mesmas |